Glacial history of Sør Rondane Mountains in Dronning Maud Land, East Antarctica introduced by geomorphology and surface exposure ages

第3回極域科学シンポジウム　横断セッション「海・陸・氷床から探る後期新生代の南極寒冷圏環境変動」11月26日（月）、27日（火） ２階ラウン

対称マルコフ過程のギルサノフ変換とその応用

Tohoku University竹田雅好課

Pressure Study of BiS2-Based Superconductors Bi4O4S3 and La(O,F)BiS2

We report the electrical resistivity measurements under pressure for the recently discovered BiS2-based layered superconductors Bi4O4S3 and La(O,F)BiS2. In Bi4O4S3, the transition temperature Tc decreases monotonically without a distinct change in the metallic behavior in the normal state. In La(O,F)BiS2, on the other hand, Tc initially increases with increasing pressure and then decreases above ? 1 GPa. The semiconducting behavior in the normal state is suppressed markedly and monotonically, whereas the evolution of Tc is nonlinear. The strong suppression of the semiconducting behavior without doping in La(O,F)BiS2 suggests that the Fermi surface is located in the vicinity of some instability. In the present study, we elucidate that the superconductivity in the BiS2 layer favors the Fermi surface at the boundary between the semiconducting and metallic behaviors.Comment: 4 pages, 6 figures, Accepted for publication in J. Phys. Soc. Jp

Tunable defect modes in chiral liquid crystals based on laser-induced modulation of helix

NanoScience + Engineering, 2007, San Diego, California, United StatesHiroyuki Yoshida, Chee Heng Lee, Yusuke Miura, Akihiko Fujii, and Masanori Ozaki "Tunable defect modes in chiral liquid crystals based on laser-induced modulation of helix", Proc. SPIE 6640, Active Photonic Crystals, 664008 (25 September 2007). DOI: https://doi.org/10.1117/12.73348

Iron Chelation Therapy with Deferasirox Results in Improvement of Liver Enzyme Level in Patients with Iron Overload-Associated Liver Dysfunction

Iron chelation therapy (ICT) has been applied for the patients with iron overload-associated liver dysfunction since it is one of the causes of death in patients with intractable hematological diseases requiring multiple red blood cell transfusions. Recently, deferasirox (DSX), a novel, once-daily oral iron chelator, was demonstrated to have similar efficacy to the conventional continuous infusion of deferoxamine on a decrease in serum ferritin (SF) level in heavily transfused patients. We show three cases of transfusion-mediated iron-overloaded patients with an elevated serum alanine aminotransaminase (ALT). All three patients who received the ICT with DSX showed a decrease in ALT level in association with a decrease in SF level. It is suggested that DSX therapy could be considered to expect the improvement of liver damage for iron-overloaded patients with an abnormal ALT level